Issued Patents 2024
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12162943 | High affinity human antibodies to human IL-4 receptor | Joel H. Martin, Tammy T. Huang, Jeanette L. Fairhurst, Nicholas J. Papadopoulos | 2024-12-10 |
| 12127537 | Genetically modified non-human animals and methods of use thereof | Richard Flavell, Markus Manz, Anthony Rongvaux, Till Strowig, Tim Willinger +2 more | 2024-10-29 |
| 12127536 | Humanized M-CSF mice | Andrew J. Murphy, Sean Stevens, Chozhavendan Rathinam, Elizabeth Eynon, Markus Manz +1 more | 2024-10-29 |
| 12037596 | Targeted modification of rat genome | Jeffrey D. Lee, Alexander O. Mujica, Wojtek Auerbach, Ka-Man Venus Lai, David M. Valenzuela | 2024-07-16 |
| 11986511 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2024-05-21 |
| 11975045 | Use of a VEGF antagonist to treat angiogenic eye disorders | — | 2024-05-07 |
| 11964016 | Combination of IL-4/IL-13 pathway inhibitors and plasma cell ablation for treating allergy | Seblewongel ASRAT, Andre Limnander, Jamie M. Orengo, Andrew J. Murphy | 2024-04-23 |
| 11912767 | EGFR × CD28 multispecific antibodies | Dimitris Skokos, Andrew J. Murphy, Chia-Yang Lin, Lauric Haber | 2024-02-27 |
| 11866503 | Methods for treating inflammatory conditions of the airway or lungs by administering antagonist monoclonal antibodies to interleukin-33 and interleukin-4 receptor | Jamie M. Orengo, Jeanne Allinne, Andrew J. Murphy | 2024-01-09 |